Please login to the form below

#DemandDiversity: We’re calling on the clinical trials industry to include us all

The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?

The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?

This is what led us to create the Include Us All campaign. As part of this campaign, a small cohort of diverse people, all with varying degrees of knowledge around clinical trials, were first given a statistic to show the representation of ethnic minority groups in COVID-19 clinical trials. Here are the statistics we shared:

Of the 270,000 people signed up to the NHS vaccine registry for COVID-19 clinical trials:

Shocking, isn’t it?

It’s been clear for a long time that ethnic minority groups are at higher risk of severe COVID-19 infections. In fact, research has shown that patients from Asian and Black ethnic groups made up 15.2% and 9.7% of critically ill patients respectively. Yet, the same groups of people are being underrepresented in clinical trials. Here’s a snippet of what the interviewees had to say about it:

“That’s quite shocking actually.”

“There’s a lot of different people from different groups that occupy this planet, so why is that statistic so small?”

“Illnesses and medication do not stop on certain races, it’s across everybody.”

How does that make you feel?

The participants were then asked how that statistic made them feel, and their emotions ranged from surprised, to angry. Further to this, all of the participants said that knowing about the diversity issue in the industry made them more motivated to take part in a clinical trial. This means that hesitancy and mistrust are not the only factors that contribute to a lack of diversity in clinical trials, because many people aren’t even aware that it’s an issue.

“It’s an assumption isn’t it, you just kind of assume that they will have trialled on everyone.”

If more people were aware of the inequalities, there’s a chance more people would want to try and solve the problem.

Why is diversity in clinical trials important?

“At the end of the day, if it’s not trialled on the right people, then it might have an adverse event.”

Simply put, if we don’t test drugs and therapies on a diverse group of people, we will never truly know if it works. Clinical trials give researchers the opportunity to identify crucial trends — what happens to those trends when we don’t even collect ethnicity data? With the ethnic minority population in the UK growing, it’s more important than ever that we ensure the medicine we’re producing works for everybody. And that means making sure that clinical trials include us all.

If you’d like to see the campaign, you can watch the full video here.

25th June 2021

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
How do ethnic minority groups in the U.S. view clinical trials?
This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
Three things to consider when using social listening research for patient recruitment
We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
4 ways mobile ethnography studies can elevate your patient insights
How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health
Include Us All in Your Clinical Trials

COUCH Health